Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone and Effects on Skin Circadian Rhythm

NCT04325802 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT04325802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04325802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone and Effects on Skin Circadian Rhythm
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Withdrawn
Start date
December 31, 2022
Completion date
June 30, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, dermatitis, pruritus, pruritus chronic